FDA TRADER retweeted
FREE FDA APPROVAL PLAY FOR SEPTEMBER $RARE ⚡️⚡️
docs.google.com/document/d/1…
FDA TRADER retweeted
FDA Approves Apellis’ EMPAVELI® (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older $APLS tinyurl.com/24w22up8
FDA TRADER retweeted
🚨Free FDA Approval play for May🚨is $ARQT PDUFA May 22, 2025
Research posted in google doc!
docs.google.com/document/d/1…
FDA TRADER retweeted
FDA Approves New Prostate Cancer Imaging Agent Gozellix® $TLX tinyurl.com/26on3xem
FDA TRADER retweeted
$TLX FDA Approves New Prostate Cancer Imaging Agent Gozellix®
globenewswire.com/news-relea…
FDA TRADER retweeted
🇦🇺Aussie biotech is soaring! $TLX up 37%! Telix's Illuccix® prostate cancer PET imaging agent gets NOMA approval for PSMA-positive lesion detection. Revenue +56%, EBITDA +70% to $99M, cash flow +80%, profit +860%, $710M cash. @jonnajarian @petenajarian #ITSNOTANOPTION
FDA TRADER retweeted
Free play research for February has been posted! Follow the link! $SWTX PDUFA Feb 28
docs.google.com/document/d/1…
FDA TRADER retweeted
TRYNGOLZA™ (olezarsen) approved in U.S. as first-ever treatment for adults living with familial chylomicronemia syndrome as an adjunct to diet $IONS tinyurl.com/226nf34n
FDA TRADER retweeted
PTC Therapeutics Announces FDA Approval of AADC Deficiency Gene Therapy $PTCT healthstockshub.com/news/nas…
FDA TRADER retweeted
JUST IN: $IOVA Walmart Posts Upbeat Earnings, Joins Armstrong World Industries, Owens & Minor And Other Big Stocks Moving Higher On Tuesday | Benzinga marketwirenews.com/articles/…
@BRTtargets @Biotechmaster12 $ACB $CPOP $AMBO










